International guidelines strongly recommend the long-term use of supplemental oxygen for patients with IPF and clinically significant resting hypoxemia (SaO2 ≤ 88% or PaO2 < 55 mm Hg while breathing room air either at rest or upon exertion). Although there is no recommendation for patients with exertional hypoxemia, oxygen therapy may help these patients increase exercise capacity.
Learn more about the medical care of patients with DPLD.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Setu K. Patolia. Fast Five Quiz: Interstitial Nonidiopathic Pulmonary Fibrosis Management - Medscape - Feb 12, 2021.